Global Thrombectomy Devices Market, By Product Type (Aspiration Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Mechanical Thrombectomy Devices, Others), Application (Cardiovascular Thrombectomy, Neurovascular Thrombectomy, Peripheral Vascular Thrombectomy), End User (Hospitals, Trauma Centres, Ambulatory Surgical Centres and Other), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2030.
Thrombectomy Devices Market Analysis and Size
As per the records of WHO, chronic diseases are the top causes of death and disability globally. Thrombectomy devices offer many benefits in surrogate endpoints, such as infarct size reduction, biomarker analysis, ST-segment resolution and angiographic thrombolysis in myocardial infarction (TIMI) flow. The increase in demand for minimally invasive surgical procedures and favourable reimbursement policies for neurovascular and cardiovascular procedures are projected to boost demand for mechanical thrombectomy devices during the forecast period.
Data Bridge Market Research analyses that the thrombectomy devices market which was USD 1.3 billion in 2022, would rocket up to USD 2.06 billion by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Thrombectomy Devices Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Product Type (Aspiration Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Mechanical Thrombectomy Devices, Others), Application (Cardiovascular Thrombectomy, Neurovascular Thrombectomy, Peripheral Vascular Thrombectomy), End User (Hospitals, Trauma Centres, Ambulatory Surgical Centres and Other), Distribution Channel (Direct Tender and Retail Sales)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Medtronic (Ireland), Inari Medical, Inc (U.S.), AngioDynamics (U.S.), Terumo Corporation (Japan), Stryker (U.S.), Zimmer Biomet (U.S.), Boston Scientific Corporation (U.S.), BD (U.S.), Straub Medical AG (Switzerland), Penumbra, Inc (U.S.), Edwards Lifesciences Corporation (U.S.), ARGON MEDICAL.(U.S.), Teleflex Incorporated (U.S.), phenox GmbH (Germany), Acandis GmbH (Germany), Merit Medical Systems (U.S.), Bayer AG (Germany), Getinge AB (Sweden), Philips Healthcare (U.S.)
Thrombectomy devices are used for the treatment of pulmonary embolism and peripheral arterial diseases. Currently, they are widely accessible in numerous sizes and diameters, depending on the affected area. Some of the most regularly used thrombectomy devices procedures are surgical embolectomy, balloon embolectomy, and aspiration embolectomy.
Thrombectomy Devices Market Dynamics
- Huge rate of Cardiac Cases
There has been increasing cases of cardiac patients that are boosting the growth of the market. For instance, in 2022,the Centre for Disease Control and Prevention (CDC) stated that 805,000 people had a heart attack in the U.S. Out of this, 605,000 are first heart attack patients and 200,000 happen to people who had a heart attack before. As per the records of an article published in the National Library of Medicine, 2022, it stated that in the U.S., around 610,000 people die of heart disease each year. Coronary heart disease is the top cause of death in the Western world killing over 370,000 people yearly. This boosts the market growth.
- Increasing Launch of New Devices
The advancement and launch of new devices such as clot retrievers, suction devices, and aspiration catheters based on advanced technology for ischemic stroke are driving the market growth. For instance, in 2021 Phenox GmbH launched pRESET 6-50 mechanically thrombectomy devices worldwide to surge its technology for acute ischemic stroke. This product has the longest stent retriever in the phenoxy product portfolio. NeuroVasv announced in 2021 that the ENVI-SR Mechanical Thrombectomy System (ENVI-SR) which is a stent-retriever is being launched by NeuroVasc Technologies for the removal of blood clots in patients who are suffering from acute ischemic stroke because of large vessel occlusion.
- Augmented Acquisitions by Several Organizations
There have been several acquisitions by multiple organizations and market players that is expanding the market growth. For instance, in July 2021, Surmodics, which is a leading provider of in vitro diagnostic technologies and medical devices, announced the acquisition of privately held Vetex Medical Limited. The Galway an Ireland-based medical device developer and manufacturer has focused completely on venous clot removal solutions. The transaction expands Surmodics’ thrombectomy portfolio with a second USFDA 510(k)-cleared device, the ReVene Thrombectomy Catheter. The ReVene mechanical thrombectomy catheter is precisely designed to remove large, mixed-morphology blood clots usually found with venous thromboembolism (VTE).
- High cost of thrombectomy devices
The high cost of thrombectomy devices, and the high risk of infection are expected to hamper the market expansion, due to price fluctuations and a scarcity of experienced experts. Furthermore, patient compatibility and other difficulties, the materials utilised to produce thrombectomy devices are not rapidly approved by several government authorities. The material that is used to make these implants is anticipated to be biocompatible and highly inert. Consequently, finding permission for these devices is tough for businesses.
This thrombectomy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the thrombectomy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Thrombectomy Devices Market
The beginning of the COVID-19 pandemic has led to an increase in patients suffering from chronic diseases. This pandemic's effects on patients' health have increased huge cases of respiratory failures leading to deaths. At the beginning of the pandemic, a major decline in the use of mechanical thrombectomy was witnessed globally. Moreover, delay in treatments using mechanical thrombectomy because of infection control measures has as well negatively impacted the market. Although COVID-19 has disturbed numerous healthcare actions, the thrombectomy devices market continued to witness robust growth.
- In 2022, Cernuous, part of Johnson & Johnson Medical Devices Companies, launched EMBOGUARD. It is a next-generation balloon guide catheter to be used in endovascular procedures in patients with acute ischemic stroke.
- In 2021, Penumbra Inc. announced that the CHEETAH clinical study of its Indigo System CA RX Catheter positively, which had met the primary endpoint, confirmed high rates of blood flow restoration, blood clot removal, and myocardial perfusion along with percutaneous coronary intervention (PCI) in patients having high thrombus burden.
Thrombectomy Devices Market Scope
The thrombectomy devices market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Aspiration Thrombectomy Devices
- Ultrasonic Thrombectomy Devices
- Mechanical Thrombectomy Devices
- Cardiovascular Thrombectomy
- Neurovascular Thrombectomy
- Peripheral Vascular Thrombectomy
- Ambulatory Surgical Centers
Thrombectomy Devices Market Regional Analysis/Insights
The thrombectomy devices market is analyzed and market size insights and trends are provided by product type, application and end-user as referenced above.
The countries covered in the thrombectomy devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the thrombectomy devices market due to the pervasiveness of numerous pharmaceuticals and biotechnology companies while high pace in technology and rising geriatric population will increase region market growth.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of increasing number of geriatric population and rise in disposable income.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The thrombectomy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for trauma devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the trauma devices market. The data is available for historic period 2011-2021.
Competitive Landscape and Global Thrombectomy Devices Market Share Analysis
The thrombectomy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to thrombectomy devices market .
Some of the major players operating in the thrombectomy devices market are:
- Medtronic (Ireland)
- Inari Medical, Inc (U.S.)
- AngioDynamics (U.S.)
- Terumo Corporation (Japan)
- Stryker (U.S.)
- Zimmer Biomet (U.S.)
- Boston Scientific Corporation (U.S.)
- BD (U.S.)
- Straub Medical AG (Switzerland)
- Penumbra, Inc (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- ARGON MEDICAL. (U.S.)
- Teleflex Incorporated (U.S.)
- phenox GmbH (Germany)
- Acandis GmbH (Germany)
- Merit Medical Systems (U.S.)
- Bayer AG (Germany)
- Getinge AB (Sweden)
- Philips Healthcare (U.S.)